Tag archive for ‘Chiasma’
Gali Weinreb On Wednesday, July 8th, 2015

Biopharma co Chiasma updates Nasdaq IPO terms

  Biopharmaceutical company Chiasma has updated the terms of its Nasdaq IPO with the US Securities and Exchange Commission (SEC). The company, which recently submitted a request for marketing approval More...

Jewish Business News On Friday, February 27th, 2015

Chiasma Raises $70 Million to Advance Its Endocrine Disease Medication

Israeli-American privately held biomed company Chiasma announced the closing of a $70 million Series E financing round. The company will use the new capital to build its sales and marketing capabilities and More...

Gil Tanenbaum On Saturday, January 3rd, 2015

Israeli-American Biomed Firm Chiasma Raises $33.8 Million to Continue Development of Oral Meds

Israeli biomed company Chiasma has raised $33.8 million out of a planned total $56.3 million round of fundraising. It plans to use the infusion of new capital to continue the development of its oral octreotide. MPM More...

Gali Weinreb On Wednesday, August 6th, 2014

Roche cancels $600 million Chiasma deal

  Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX: ROG) has notified Israeli startup Chiasma that it has cancelled More...

Wordpress site Developed by Fixing WordPress Problems